Try our Advanced Search for more refined results
Argentum Pharmaceuticals LLC v. Research Corporation Technologies, Inc.
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Argentum Pharmaceuticals LLC
Patent Owner:
Research Corporation Technologies, Inc.
Tech Center:
1600
-
April 07, 2020
PTAB Says Printed Publication Rules Differ For Exams, IPRs
The Patent Trial and Appeal Board said in a precedential decision Tuesday that the rules for determining whether a printed publication was publicly available and can be used to invalidate a patent are different during patent examination than in inter partes reviews.
-
March 23, 2017
PTAB Upholds Vimpat Patent In Generic Makers' Challenge
The Patent Trial and Appeal Board upheld a Research Corp. Technologies Inc. patent for the anti-epileptic drug Vimpat on Wednesday, just months after a Delaware federal judge refused to invalidate part of the patent in an infringement suit brought against generic-drug makers.
-
May 24, 2016
Generic Drugmaker Wins Review Of UCB's Vimpat Patent
The Patent Trial and Appeal Board on Monday accepted generic drugmaker Argentum Pharmaceuticals' petition to review a patent for UCB Inc.'s epilepsy drug Vimpat.